|
1
|
Jančo L, Tkáčová Villemová K, Ondrejková
M, Vida R, Bartoš M and Mesárošová M: Retinal tamponade with
silicone oil - long term results. Cesk Slov Oftalmol. 70:178–182.
2014.(In Czech). PubMed/NCBI
|
|
2
|
Scheerlinck LM, Schellekens PA, Liem AT,
Steijns D and Leeuwen R: Incidence, risk factors, and clinical
characteristics of unexplained visual loss after intraocular
silicon oil for macula-on retinal detachment. Retina. 36:342–350.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miller JB, Papakostas TD and Vavvas DG:
Complications of emulsified silicone oil after retinal detachment
repair. Semin Ophthalmol. 29:312–318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Z and Luan J: Clinical observations
of secondary glaucoma post silicone oil tamponade. Chin J Ocul
Fundus Dis. 27:363–365. 2011.
|
|
5
|
Wasilewska A, Winiarska M, Olszewska M and
Rudnicka L: Interleukin-17 inhibitors. A new era in treatment of
psoriasis and other skin diseases. Postepy Dermatol Alergol.
33:247–252. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang F: Efficacy of selective laser
trabeculoplasty in the treatment of secondary glaucoma eye after
silicone oil tamponade. Chin J Prim Med Pharm. 21:2475–2477.
2014.
|
|
7
|
Dooley IJ, Duignan ES and Kilmartin DJ:
Long-term heavy silicone oil intraocular tamponade. Int Ophthalmol.
36:3–7. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Teke MY, Elgin U, Sen E, Ozdal P and
Ozturk F: Intravitreal silicone oil induced changes in corneal
biomechanics. Int Ophthalmol. 34:457–463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kong YL, Hu XR, Gao JH and Zheng LD:
Clinical analysis of secondary glaucoma after silicone oil
tamponade. Shanxi Med J. 42:1280–1281. 2013.
|
|
10
|
Gao L and Liu S: Anterior chamber silicone
oil emulsion. Zhonghua Yan Ke Za Zhi. 50:379. 2014.(In
Chinese).
|
|
11
|
Rosca C, Munteanu M, Tamasoi I, Petrovic
Z, Balica N, Nicula C and Cretu O: Calcification of hydrophilic
acrylic intraocular lens in eyes with silicone oil tamponade - an
interventional case series report. Acta Ophthalmol. 94:625–627.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ichhpujani P, Jindal A and Jay Katz L:
Silicone oil induced glaucoma: A review. Graefes Arch Clin Exp
Ophthalmol. 247:1585–1593. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Farrahi F, Feghhi M, Ostadian F and
Alivand A: Pars plana vitrectomy and silicone oil injection in
phakic and pseudophakic eyes; corneal endothelial changes. J
Ophthalmic Vis Res. 9:310–313. 2014.PubMed/NCBI
|
|
14
|
Falavarjani KG, Modarres M and Nazari H:
Therapeutic effect of bevacizumab injected into the silicone oil in
eyes with neovascular glaucoma after vitrectomy for advanced
diabetic retinopathy. Eye (Lond). 24:717–719. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zoric Geber M, Bencic G, Vatavuk Z,
Ivekovic R and Friberg TR: Retinal nerve fibre layer thickness
measurements after successful retinal detachment repair with
silicone oil endotamponade. Br J Ophthalmol. 99:853–858. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo XQ, Tian B, Liu ZC, Wei WB, Tao Y, Sun
SJ and Zhang Y: A new rat model of glaucoma induced by intracameral
injection of silicone oil and electrocoagulation of limbal vessels.
Chin Med J (Engl). 124:309–314. 2011.PubMed/NCBI
|
|
17
|
Zhang M, Li B, Wang J, Liu W, Sun Y and Wu
X: Clinical results of selective laser trabeculoplasty in silicone
oil-induced secondary glaucoma. Graefes Arch Clin Exp Ophthalmol.
252:983–987. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ohira S, Inoue T, Iwao K, Takahashi E and
Tanihara H: Factors influencing aqueous proinflammatory cytokines
and growth factors in uveitic glaucoma. PLoS One. 11:e01470802016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yi Z, Jiang S, Liu T and Du EG: Effects of
ranibizumab on the serum and aqueous humor IL-6 and VEGF in
patients with neovascular glaucoma. Chin J Biol Pharm. 36:151–153.
2016.
|
|
20
|
Guedes MC, Borrego LM and Proença RD:
Roles of interleukin-17 in uveitis. Indian J Ophthalmol.
64:628–634. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Speeckaert R, Lambert J, Grine L, Van Gele
M, De Schepper S and van Geel N: The many faces of interleukin-17
in inflammatory skin diseases. Br J Dermatol. 175:892–901. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Boshtam M, Asgary S, Kouhpayeh S, Shariati
L and Khanahmad H: Aptamers against pro- and anti-inflammatory
cytokines: A review. Inflammation. 40:340–349. 2016. View Article : Google Scholar
|
|
23
|
Bećarević M: TNF-alpha and annexin A2:
Inflammation in thrombotic primary antiphospholipid syndrome.
Rheumatol Int. 36:1649–1656. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kumari N, Dwarakanath BS, Das A and Bhatt
AN: Role of interleukin-6 in cancer progression and therapeutic
resistance. Tumour Biol. 37:11553–11572. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qin Y, Chen X, Liu J and Dai SY: The
expression of aqueous humor IL-17 in patients with secondary
glaucoma caused by silicon oil tamponade and its relationship with
glaucoma. Chin J Ocul Trauma Occup Eye Dis. 38:365–368. 2016.
|
